Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
5,856.50
-50 (-0.85%)
BSENSE

Apr 02

BSE+NSE Vol: 5.31 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,856.50",
    "chg": -50,
    "chgp": "-0.85%",
    "dir": -1,
    "prev_price": "5,906.50",
    "mcapval": "150,684.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "5.31 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Divis Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-divis-laboratories-ltd-fallingrising-3931199",
        "imagepath": "",
        "date": "2026-04-03 01:25:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Divis Laboratories has experienced a consistent downward trend over the past week, with a one-week return of -2.53%, closely mirroring the Sensex’s decline of -2.60%. Over the last month, the stock has fallen by 8.47%, again tracking the benchmark’s 8.62% drop. Year-to-date, the stock is down 8.35%, though this is notably better than the Sensex’s 13.96% decline. Despite these short-term setbacks, the stock has delivered a positive 3.46% return over the past year, outperforming the Sensex’s negative 4.30% return. The longer-term performance is even more impressive, with a three-year gain of 107.41% compared to the Sensex’s 24.29%, and a five-year return of 62.12% against the benchmark’s 46.55%.</p>\n<p>On 02-Apr, the stock touched an int..."
      },
      {
        "title": "Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 2 Apr 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-2-apr-2026-3929794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_priceRelatedfactors_3929794.png",
        "date": "2026-04-02 09:31:06",
        "description": "Shares of Divis Laboratories Ltd declined sharply on 2 Apr 2026, touching an intraday low of Rs 5,702, reflecting sustained price pressure amid a broadly weak market environment and sectoral downturn. The stock underperformed its Pharmaceuticals & Biotechnology sector peers and the broader Sensex index, continuing a recent trend of subdued performance."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bearish-momentum-3929326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3929326.png",
        "date": "2026-04-01 15:00:12",
        "description": "Divis Laboratories Ltd (DIVISLAB), a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.8% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price trends, offers critical insights into evolving market positioning and potential directional bets among investors."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3922748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_mojoScore_3922748.png",
        "date": "2026-03-29 10:10:26",
        "description": "Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date perspective on the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Divis Laboratories Gains 0.57%: Mixed Signals Shape Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-057-mixed-signals-shape-weekly-performance-3922575",
        "imagepath": "",
        "date": "2026-03-29 09:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Technical downgrade signals bearish momentum</p>\n                    <p><strong>20 Mar:</strong> Intraday high surge of 3.0% to Rs.6,158.95</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.6,102.25 (+0.57%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,067.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6,102.25</div><div class=\"stat-change positive\">+0.57%</div></div>\n                    <div class=\"stat-item\"><div ..."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3920055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3920055.png",
        "date": "2026-03-27 15:00:28",
        "description": "Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 18.04% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price gain of 0.07%, the stock’s trading volumes and open interest dynamics suggest evolving directional bets amid a broader market downturn."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3919844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3919844.png",
        "date": "2026-03-27 14:00:20",
        "description": "Divis Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price gain of 0.53% on 27 Mar 2026, the pharmaceutical giant’s futures and options data reveal a complex interplay of bullish and cautious bets amid broader sector and market headwinds."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3919524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3919524.png",
        "date": "2026-03-27 13:00:12",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price gain of 0.20% on 27 Mar 2026, the underlying dynamics suggest a complex interplay of directional bets and liquidity flows that merit close attention from investors and analysts alike."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3916489.png",
        "date": "2026-03-25 15:00:34",
        "description": "Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.11% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock’s price performance remains subdued relative to its sector peers, reflecting a complex interplay of market sentiment and technical factors."
      }
    ],
    "total": 607,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Other General Purpose",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana'.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Updates",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Divis Laboratories Ltd falling/rising?

2026-04-03 01:25:03

Recent Price Movement and Market Context

Divis Laboratories has experienced a consistent downward trend over the past week, with a one-week return of -2.53%, closely mirroring the Sensex’s decline of -2.60%. Over the last month, the stock has fallen by 8.47%, again tracking the benchmark’s 8.62% drop. Year-to-date, the stock is down 8.35%, though this is notably better than the Sensex’s 13.96% decline. Despite these short-term setbacks, the stock has delivered a positive 3.46% return over the past year, outperforming the Sensex’s negative 4.30% return. The longer-term performance is even more impressive, with a three-year gain of 107.41% compared to the Sensex’s 24.29%, and a five-year return of 62.12% against the benchmark’s 46.55%.

On 02-Apr, the stock touched an int...

Read full news article

Divis Laboratories Gains 0.57%: Mixed Signals Shape Weekly Performance

2026-03-29 09:00:05

Key Events This Week

16 Mar: Technical downgrade signals bearish momentum

20 Mar: Intraday high surge of 3.0% to Rs.6,158.95

20 Mar: Week closes at Rs.6,102.25 (+0.57%) outperforming Sensex

stock-recommendationAnnouncement

Divi's Laboratories Limited - Other General Purpose

03-Dec-2019 | Source : NSE

Divi's Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates

18-Nov-2019 | Source : NSE

Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Divi's Laboratories Limited - Updates

15-Nov-2019 | Source : NSE

Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana'.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Divis Laboratories Ltd has declared 1500% dividend, ex-date: 25 Jul 25

stock-summary
SPLITS

Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07

stock-summary
BONUS

Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15

stock-summary
RIGHTS

No Rights history available